These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15804873)

  • 1. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response.
    Kosten T; Sofuoglu M; Poling J; Gonsai K; Oliveto A
    Am J Addict; 2005; 14(1):8-17. PubMed ID: 15804873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.
    Kosten T; Falcioni J; Oliveto A; Feingold A
    Am J Addict; 2004; 13(2):191-201. PubMed ID: 15204669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M; Gonzalez G; Poling J; Kosten TR
    Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
    Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
    Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
    Feingold A; Oliveto A; Schottenfeld R; Kosten TR
    Am J Addict; 2002; 11(2):111-23. PubMed ID: 12028741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
    Kosten TR; Morgan CM; Falcione J; Schottenfeld RS
    Arch Gen Psychiatry; 1992 Nov; 49(11):894-8. PubMed ID: 1444728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desipramine treatment of cocaine dependence in methadone-maintained patients.
    Arndt IO; Dorozynsky L; Woody GE; McLellan AT; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):888-93. PubMed ID: 1444727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.
    Kosten T; Poling J; Oliveto A
    Addiction; 2003 May; 98(5):665-71. PubMed ID: 12751984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.
    Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S
    Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
    Arndt IO; McLellan AT; Dorozynsky L; Woody GE; O'Brien CP
    J Nerv Ment Dis; 1994 Mar; 182(3):151-6. PubMed ID: 8113775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.
    George TP; Chawarski MC; Pakes J; Carroll KM; Kosten TR; Schottenfeld RS
    Biol Psychiatry; 2000 Jun; 47(12):1080-6. PubMed ID: 10862808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
    Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
    Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.
    Gerra G; Zaimovic A; Raggi MA; Moi G; Branchi B; Moroni M; Brambilla F
    Psychiatry Res; 2007 Jan; 149(1-3):201-13. PubMed ID: 17129610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients.
    Tzilos GK; Rhodes GL; Ledgerwood DM; Greenwald MK
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):320-5. PubMed ID: 19803631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.